Signed in as:
- Who we are
- Join Us
- Next meeting - 19 Sept
- Education: Teach-Hub
- UIC Symposium 2023
- Contact Us
- SCCAC Opinion
- Meeting recordings
- INTERNATIONAL PAIN SURVEY
Signed in as:
CCA is an educational and scientific organisation of qualified physicians and other professionals dedicated to the promotion, protection and support of cannabis for medical use.
NEW MEMBERS ARE WELCOME - MEMBERSHIP IS COMPLIMENTARY THROUGH MEMBERSHIP OF CCA'S PARENT ORGANISATION, THE AUSTRALIAN MEDICINAL CANNABIS ASSOCIATION (AMCA).
JUST CLICK THE CCA LOGO TO THE RIGHT TO GO TO THE "JOIN US" PAGE
Dr Nick Giummara is a fully qualified, vocationally registered GP with the FRACGP.
After many years of working as a family doctor, he decided to sub-specialise in this exciting field of medicine whilst working from home and spending more time with his young family.
Having been a part of busy medical practices, he has a strong desire to keep the number of patients he sees capped to ensure quality, personalised and attentive service, whilst being available for reliable follow up.
He believes there is growing evidence that supports medicinal cannabis’ ability to help patients where other pharmaceuticals have failed, and will encourage new patients to join clinical trials to help grow the evidence.
Although he does not guarantee patients that initial consultations will lead to prescriptions, he assures them that any advice given takes into account, their holistic circumstances, as well as the medical recommendations.
Dr. David Gunn is a Canadian doctor who moved with his family to the Northern Rivers, NSW in 2017.
He currently works in Lismore, as a GP with special interests in Mental Health, Sports Medicine, Addictions Medicine, Palliative Care, Geriatrics, Autism Spectrum Disorder, Chronic Progressive Neurologic Disorders, Chronic pain and the medical use of Cannabinoids.
The first 12 years of his career revolved around a small but busy general hospital in Nova Scotia, Canada, where in addition to his GP duties he worked in: emergency medicine, inpatient care, nursing home care, palliative care, and opioid replacement medicine.
In addition to many years of prescribing cannabinoids in Canada, Dr Gunn continues to prescribe them here in Australia in his family practice and has been appointed as a Medical Advisor for Emerald Clinics, which are specialist referral only clinics in WA and NSW.
He has completed the Australian Medical Cannabis Course for Healthcare Professionals from UIC and the Australian National University. Dr Gunn has also received training from Dr Danial Schecter the Co-founder and Medical Director of the Canadian Cannabinoid Medical Clinics, which are the largest referral only medical cannabinoid clinics in Canada.
Dr. Matty Moore was born and raised in Austin, Texas USA. He attended Baylor University where he gained a BA in Biology. He then attended Ross University in Dominica, West Indies. Following his residency at the University of Wyoming Family Medicine Program, Rural GP Training, Matty moved into private practice in Wyoming before moving to Australia
After initially working in a busy Emergency Department in Townsville, QLD, Matty moved back into General Practice, which took his family over to Western Australia - the perfect place for Matty and his wife to grow their family. He now works as an SMO (Senior Medical Officer) in Busselton Emergency Department and as a GP at Dunsborough Medical Centre. His interest in medicinal cannabis stems from the movement and acceptance of its properties in the USA and around the world.
Matty was looking for alternative treatments for several conditions whose management had become quite stagnant and frustrating. After government legislation in 2016 which allowed GP's to prescribe cannabis, Matty began to educate himself on the history of cannabis, the cannabis plant, and the endocannabinoid system. He has since been approved by the TGA and WA Health to become one of a very few group of doctors Australia-wide deemed as an ‘Authorized Prescriber.’ The clinical applications are exciting, and as we amass the data needed to turn the tide, Matty has decided to join the fight against the age-old propaganda and embrace this plant and its healing properties.
Justin joined the Australian Natural Therapeutics Group in March 2021 as Chief Scientific Officer with ANTG.
Previously a Research Fellow at the NICM Health Research Institute at the University of Western Sydney, Justin coordinated the Australian Medicinal Cannabis Research & Education Collaboration (AMCREC).
Justin is a member of the Society of Cannabis Clinicians Australian Chapter (SCCAC) Advisory Panel and has also served as an advisor to United in Compassion, Australia’s leading medicinal cannabis patient advocacy group, in a pro bono capacity, since January 2015.
Justin's scientific background is in pharmacognosy (i.e. drugs that come from plants, fungi and natural sources), but his research interests extend into botany, ethnopharmacology, analytical phytochemistry and psychopharmacology. He is currently a co-investigator on several medicinal cannabis clinical research projects and has presented over 70 medicinal cannabis lectures to medical practitioners, nurses, pharmacists and the general public since 2016.
Justin has published on the topics of cannabis and the endocannabinoid system, pain management and herb/drug interactions in peer reviewed publications and is currently pursuing research focusing on the safety, tolerability and effectiveness of medicinal cannabis for endometriosis.
Dr Joel Wren is a GP and Cannabis clinician working in Adelaide, South Australia.
Joel has long been fascinated with plant-based pharmaceuticals, growing to appreciate the potential of our natural world. Seeing his patients' hunger for natural medicines prompted him to learn more about holistic health, taking into consideration every aspect of a patient's health journey including social, mental, physical, and nutritional health.
Joel was chosen to present to the United Nations Commission on Narcotic Drugs (CND) on behalf of the Society of Cannabis Clinicians to discuss the rescheduling of MC from archaic classifications. He has since become the President of the Australian Chapter.
When Joel isn’t working, he’s looking after his 3 dogs and advocating for animal wellbeing, understanding that their journey can be as important and complicated as our own.
Late last year, Dr. Jim Connell stepped down from the role of President due to family commitments and time constraints. We'd like to thank Jim for the input he gave to SCCAC during his time as President.
Vice President, Dr. Joel Wren, stepped up with so many important projects on the table. Joel has extensive knowledge in medicinal cannabis and was chosen to present to the United Nations Commission on Narcotic Drugs (CND) on behalf of the Society of Cannabis Clinicians to discuss the rescheduling of MC from archaic classifications.
SCCAC is seeking nominations from any current medical practitioner members who may be interested in putting their name forward as a potential new Vice President to be decided at our first General Meeting for the new year on 15/02/22. Please submit your interest to our General Manager, Gail Wiseman through email@example.com by 08/02/22.
1. Expansion of knowledge on the medical use of cannabis
2. Facilitation of best practice standards for cannabis consultations
3. To study, discuss and make recommendations relating to research, practice and policy in the medical use of cannabis
4. To further the recruitment of medical graduates and able physicians willing to recommend cannabis to patients
5. To maintain and advance the highest possible ideals and service standards in the education, practice and research in the medical use of cannabis.
The Australian Medicinal Cannabis Association (AMCA) and The Society of Cannabis Clinicians of the USA have announced the formation of the Australian chapter of The Society of Cannabis Clinicians.
The formation of the Society of Cannabis Clinicians Australian Chapter (SCCAC) follows the significant growth in prescribers and prescriptions since medical cannabis was legalised in 2016.
Founding member and AMCA general manager Gail Wiseman said: “The establishment of the Society of Cannabis Clinicians – Australian Chapter was the first major project for AMCA and we are excited to see how well supported it has already been by its founding group of nearly 20 dedicated individuals.
“We see SCCAC bringing all of the advantages offered by the international SCC organisation while uniting and meeting the specific needs of Australian-based health care practitioners (HCPs) and their affiliates.
“SCCAC had its inaugural meeting on November 3 and its priority interests were very clear – a strong focus on providing education to interested HCPs on the endocannabinoid system and best-practice prescribing of medicinal cannabis, and reducing the stigma associated with the use of medicinal cannabis.
“AMCA and SCC will continue to provide administrative support to the fledgling SCCAC whilst allowing it to operate as an independent, non-political organisation.”
The goals of the organisation are to educate people about medical cannabis; facilitate best practice standards for cannabis consultations; study, discuss and make recommendations relating to research, practice and policy in the medical use of cannabis; recruit medical graduates and physicians willing to recommend cannabis to patients; and to maintain and advance the highest possible ideals and service standards in education, practice and research in the medical use of cannabis.
At SCCAC’s inaugural meeting, Dr James Connell was elected president with Dr Joel Wren named vice president of the association.
The society has 17 founding members and new members are welcome.
For more information or to join SSCAC, email firstname.lastname@example.org.